comorbidities for glp 1 Big policy shift in obesity medicine. Starting July 1, 2026, Medicare will launch a temporary “GLP-1 Bridge” program allowing eligible patients to access drugs like Zepbound and Wegovy about $50/month. For Proposed algorithm for prescribing GLP-1

Here are just a few: Target the Root Cause While GLP-1s tackle the symptoms of weight loss to curb your appetite and control blood sugar, nonsurgical procedures go straight to the root cause by physically reducing stomach size or limiting food intake

7 In particular, weight loss induced by GLP-1 RAs has been associated with significant improvement in debilitating headaches, especially in conditions such as idiopathic intracranial hypertension (IIH) and migraine, both of which are known to be exacerbated by obesity and its associated systemic inflammation

Compounded tirzepatide drops to $219 a month on a three-month plan and $199 a month on a six-month plan

In clinical development, AI is helping to predict patient responses, streamline trial design, and identify optimal dosing strategies

COMPLETE SYSTEM Use Both Together COMPLETE SYSTEM For the strongest, most sustainable results, use LOAD + the GLP-1 Vitamin Support Pack together

Scottsdale and Phoenix, Arizona